Insulin aspart, recombinant Subcutaneous and Phenylephrine and Pyrilamine Liquid
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Phenylephrine and Pyrilamine Liquid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: phenylephrine / pyrilamine nasal
Brand name: Ru-Hist-D
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Phenylephrine and Pyrilamine Tablets
- Insulin aspart, recombinant Subcutaneous-Phenylephrine and Thonzylamine
- Insulin aspart, recombinant Subcutaneous-Phenylephrine and triprolidine
- Insulin aspart, recombinant Subcutaneous-Phenylephrine Complex
- Insulin aspart, recombinant Subcutaneous-Phenylephrine Eye Drops 10%
- Insulin aspart, recombinant Subcutaneous-Phenylephrine Eye Drops 2.5%
- Phenylephrine and Pyrilamine Liquid-Insulin degludec
- Phenylephrine and Pyrilamine Liquid-Insulin Degludec (U-100) Prefilled Pens
- Phenylephrine and Pyrilamine Liquid-Insulin Degludec (U-100) Vials
- Phenylephrine and Pyrilamine Liquid-Insulin Degludec (U-200) Prefilled Pens
- Phenylephrine and Pyrilamine Liquid-Insulin degludec and liraglutide
- Phenylephrine and Pyrilamine Liquid-Insulin degludec and liraglutide Subcutaneous